Early myopia prevention study for young children
Treatments studied
Part of Eyes & vision clinical trials.
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 3 and 6 years old.
- Your child has mild nearsightedness or farsightedness (within a certain range after eye drops are used).
- Your child does not have other eye problems like crossed eyes (strabismus), lazy eye (amblyopia), or cataracts.
- Your child has not used special contact lenses, atropine eye drops, or other myopia treatments in the last 4 weeks.
- Your child can understand instructions and cooperate to wear glasses as needed.
- You (as a guardian) can agree to regular check-ups and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests special glasses designed to slow or prevent nearsightedness (myopia) in young children ages 3 to 6. It may help if your child has mild farsightedness or low nearsightedness and at least one parent is nearsighted.
This study tests if using atropine eye drops in increasing doses can prevent nearsightedness (myopia) in children who are at risk. It is for children aged 6 to 9 who do not yet need glasses but have early signs of developing myopia.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.